Along this line, we reported a case harboring an ESR1 mutation, in which the variant allele frequency raised from 2,6% in the primary tumor sample to 8,8% in the metastatic sample, letting us speculate that this could represent an example of clonal expansion upon therapy selective pressure. Here, ESR1 is linked to neoplasm.